Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Capital-Lease-Obligations" stands at 1.90 Billion United States Dollars as of 09/30/2025, the highest value since 09/30/2021.
As of the end of Novartis AG's third quarter, the item "Capital Lease Obligations" stands at 1.90 Billion USD. This represents an increase of 2.75 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.31 percent compared to the value the year prior.
The 1 year change in percent is 3.31.
The 3 year change in percent is 8.74.
The 5 year change in percent is -2.41.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Capital Lease Obligations | 905,699,262,464.00 |
![]() | Johnson & Johnson - Capital Lease Obligations | 486,508,953,600.00 |
![]() | AbbVie Inc - Capital Lease Obligations | 399,570,305,024.00 |
![]() | Roche Holding AG - Capital Lease Obligations | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Capital Lease Obligations | 280,205,508,085.11 |